Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Kee Pharma Limited, is an unlisted public company incorporated on 08 May, 1991. It is classified as a public limited company and is located in , Delhi. It's authorized share capital is INR 11.00 cr and the total paid-up capital is INR 10.48 cr.
Kee Pharma Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's book networth has decreased by 104.5%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Varun Motihar | 01395649 | 11 years |
| Managing Director | Anil Motihar
Shareholder
|
00028081 | 33 years |
| Director | Harinder Motihar
Shareholder
|
01240251 | 10 years |
| Additional Director | Natasha Goyal | 07066059 | 0 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Indian Bank
No. of Loans: 6
Total Amount : 5.8 cr
NIDIAN BANK
No. of Loans: 3
Total Amount : 1.8 cr
HSIDC
No. of Loans: 1
Total Amount : 1.0 cr
HARYANA STATE INDUSTRIAL DEVELOPMENT COR. LTD.
No. of Loans: 1
Total Amount : 0.9 cr
GE Capital Services India
No. of Loans: 1
Total Amount : 0.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| HELVETICA INDUSTRIES PRIVATE LIMITED |
Active
|
46.7 L | 1 | Delhi |
| KEE DIAGNOSTICS PRIVATE LIMITED |
Active
|
2.8 Cr | 1 | Delhi |
| KEE HEALTHCARE PRIVATE LIMITED |
Active
|
10.0 L | 2 | Delhi |
| HARITIMA TOURS & TRAVELS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| HINDUSTAN THERMALPROJECTS LIMITED |
Active
|
14.5 Cr | 1 | Delhi |
| HINDUSTAN POWERPROJECTS PRIVATE LIMITED |
Active
|
1,393.7 Cr | 1 | Delhi |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| KEE DIAGNOSTICS PRIVATE LIMITED | Delhi | 2004 | ₹ 2.8 Cr |
| KEE HEALTHCARE PRIVATE LIMITED | Delhi | 2012 | ₹ 10.0 L |
| HELVETICA INDUSTRIES PRIVATE LIMITED | Delhi | 1999 | ₹ 46.7 L |
Read more
The incorporation date of KEE PHARMA LIMITED is 08 May, 1991
The authorized share capital of KEE PHARMA LIMITED is INR ₹ 11.0 Cr.
The paid-up capital of KEE PHARMA LIMITED is INR ₹ 10.5 Cr.
The registered address of KEE PHARMA LIMITED is A - 8, 3RD FLOOR, NARAINA INDUSTRIAL AREA, PHASE - II, South West Delhi, NEW DELHI, Delhi, India, 110028 - 110028
The CIN number of KEE PHARMA LIMITED is U24239DL1991PLC044264.